Editorial: NRF2 signaling pathway: New insights in the field of reno-cardiovascular health

Front Pharmacol. 2023 Apr 17:14:1193005. doi: 10.3389/fphar.2023.1193005. eCollection 2023.

Zeba Farooqui¹, Juan Antonio Moreno^{2

3

4}, Alfonso Rubio-Navarro^{5

6

7}

¹ College of Pharmacy, Heart and Kidney Institute, University of Houston, Houston, TX, United States.
² Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Hospital Universitario Reina Sofía, Córdoba, Spain.
³ Department of Cell Biology, Physiology and Immunology, University of Cordoba, Cordoba, Spain.
⁴ Biomedical Research Networking Center on Cardiovascular Diseases (CIBERCV), Madrid, Spain.
⁵ Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Granada, Spain.
⁶ Laboratory of Advanced Therapies (CTS-963): Differentiation, Regeneration and Cancer, Center of Biomedical Research, University of Granada, Granada, Spain.
⁷ Excellence Research Unit "Modeling Nature" (MNat), University of Granada, Granada, Spain.

No abstract available

Keywords: NRF2; cardiovascular disease; inflammation; oxidative stress; renal disease.

Publication types